Skip to content

Penile Skin Versus Buccal Mucosal Graft in Augmentation Urethroplasty for Long Anterior Urethral Stricture

Penile Skin Versus Buccal Mucosal Graft in Augmentation Urethroplasty for Long Anterior Urethral Stricture: A Prospective Randomized Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07074717
Enrollment
80
Registered
2025-07-20
Start date
2025-01-01
Completion date
2025-12-01
Last updated
2025-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Augmentation, Buccal Mucosal Graft, Long Anterior, Penile Skin, Urethral Stricture, Urethroplasty

Brief summary

The aim of this study is to analyze the outcomes of dorsal onlay buccal mucosal graft (BMG) and penile skin graft (PSG) urethroplasty in the management of long segment bulbar urethral stricture.

Detailed description

Penile urethral reconstruction proves to be a continuous challenge as no perfect technique is considered for all patients with this problem. Among all the methods used for treatment of urethral stricture, the substitution urethroplasty with tissue transfer using either flap or graft is the gold standard treatment option for long segment urethral strictures. In 1993, McAninch described a circular fasciocutaneous flap for the management of penile urethral stricture up to 15 cm that showed excellent cosmetic and functional outcomes due to this being a hairless, flexible flap with a rich vascular supply. Buccal mucosal graft (BMG) was rediscovered and popularized in 1992 by Burger et al., then El-Kassaby et al. in 1993 published a series using buccal mucosal graft to repair anterior urethral stricture. Buccal mucosal graft became an ideal urethral substitute due to easy harvesting, hairlessness and compatibility in a wet environment.

Interventions

PROCEDUREBuccal Mucosal Graft (BMG) Urethroplasty

Urethroplasty using a buccal mucosal graft harvested from the inner cheek. The graft is dorsally onlaid to reconstruct the strictured urethral segment. The procedure is conducted under spinal or general anesthesia.

PROCEDUREPenile Skin Graft (PSG) Urethroplasty

Urethroplasty using a penile skin graft harvested from the ventral surface of the penis. The graft is applied dorsally after excision of the fibrotic urethral segment. The surgery is performed under spinal or general anesthesia.

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with long segment anterior urethral stricture that was defined as a stricture with a length of more than 1 cm with spongiofibrosis. * Patients with previous failed urethral dilatation or direct vision internal urethrotomy (DVIU)

Exclusion criteria

* Patients with lichen sclerosus * Patients with history of hypospadias repair * Patients with recurrent urethral stricture after failed previous urethroplasty

Design outcomes

Primary

MeasureTime frameDescription
Surgical Success Rate9 months postoperativelySuccess is defined as satisfactory urinary stream with no need for further intervention (such as dilatation or DVIU) and no evidence of stricture on retrograde urethrogram during follow-up.

Secondary

MeasureTime frameDescription
Length of Urethral StrictureIntraoperativelyLength of Urethral Stricture will be measured to compare the characteristics of strictures managed by each graft technique.
Postoperative Complications9 months postoperativelyComplications such as infection, bleeding, graft failure, and fistula formation following surgery will be recorded.
International Prostate Symptom Score (IPSS)9 months postoperativelyEvaluation of changes in urinary symptoms using International Prostate Symptom Score (IPSS) to assess functional outcome and patient comfort after urethroplasty will be assessed.

Countries

Egypt

Contacts

Primary ContactMohamed I Elmaadawy, MD
Mohamed.elmaadawy@med.tanta.edu.eg00201060245430

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026